Astec LifeSciences Limited has informed the Exchange regarding Outcome of Rights Issue Committee Meeting held on July 02, 2025.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec LifeSciences Limited has approved the Letter of Offer for its proposed Rights Issue on July 2, 2025. The company plans to issue up to 28,01,673 equity shares with a face value of ₹10 each at an issue price of ₹890 per share, raising approximately ₹249.35 crore (assuming full subscription). Eligible shareholders can subscribe in the ratio of 1 rights share for every 7 fully paid-up shares held as on the record date of Friday, July 4, 2025. The Letter of Offer will be filed with BSE, NSE, and SEBI, and made available on the company's website.
Existing shareholders will need to decide whether to subscribe to their entitlement or let it lapse. The rights issue will dilute existing holdings by approximately 14.3% (1/7 ratio), but brings in fresh capital of up to ~₹249 crore if fully subscribed.